Story perspectives

FDA Plans to Lift Most Black Box Warnings on Meds

11/24/2025

34 4

Summary

Story summary

On November 10, the U.S. Food and Drug Administration announced plans to remove most "black box" warnings.
The decision follows advocacy from medical professionals and patients, citing older studies.
Current research indicates these medications are safer, particularly for women under 60.
Local low-dose estrogen therapies carry minimal risk and systemic therapies may increase the risk of breast cancer and blood clots.
Insurance coverage varies, with generic treatments generally covered.

1 of 1

Story summary

On November 10, the U.S. Food and Drug Administration announced plans to remove most "black box" warnings.
The decision follows advocacy from medical professionals and patients, citing older studies.
Current research indicates these medications are safer, particularly for women under 60.
Local low-dose estrogen therapies carry minimal risk and systemic therapies may increase the risk of breast cancer and blood clots.
Insurance coverage varies, with generic treatments generally covered.